ARQT icon

Arcutis Biotherapeutics

185 hedge funds and large institutions have $1.18B invested in Arcutis Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

0.57% more ownership

Funds ownership: 108.71%109.28% (+0.57%)

5% less capital invested

Capital invested by funds: $1.24B → $1.18B (-$61.9M)

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
185
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.03M
Puts
$2.73M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
101
$448K
102
$419K
103
$406K
104
$395K
105
$375K
106
$351K
107
$340K
108
$339K
109
$329K
110
$269K
111
$268K
112
$266K
113
$259K
114
$257K
115
$246K
116
$246K
117
$242K
118
$225K
119
$215K
120
$213K
121
$211K
122
$201K
123
$191K
124
$186K
125
$176K